Tumores renales pediátricos

1 PDQ Pediatric Treatment Editorial Board. Wilms tumor and other childhood kidney tumors treatment (PDQ): health professional version. PDQ cancer information summaries. National Cancer Institute. June 13, 2019. https://www.cancer.gov/types/kidney/hp/wilms-treatment-pdq (accessed Sept 1, 2019).

2 Van den Heuvel-Eibrink MM, Hol JA, Pritchard-Jones K, et al. Position paper: rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol. Nat Rev Urol 2017; 14: 743–52. Search strategy and selection criteria Data for this review were identified from searches of

MEDLINE, PubMed, and references from relevant articles using the search terms “children” or “infants” or “paediatric” or “pediatric”, and “Wilms’ tumour” or “clear cell sarcoma” or “rhabdoid tumour” or “cystic partially differentiated nephroblastoma” or “cystic nephroma” or “multiloculated cystic nephroma” or “mesoblastic nephroma”, and “MRI” or “diffusion weighted imaging” or “CT” or “positron emission tomography” or “ultrasound”. Abstracts and meeting reports were not included. Only articles published in English between January, 2000, and April, 2019, were included.

3 Irtan S, Van Tinteren H, Graf N, et al. Evaluation of needle biopsy as a potential risk factor for local recurrence of Wilms tumour in the SIOP WT 2001 trial. Eur J Cancer 2019; 116: 13–20.

4 Jackson TJ, Williams RD, Brok J, et al. The diagnostic accuracy and clinical utility of pediatric renal tumor biopsy: report of the UK experience in the SIOP UK WT 2001 trial. Pediatr Blood Cancer 2019; 66: e27627.

5 Stiller CA, Olshan AF. Epidemiology of renal tumours of childhood. In: Pritchard-Jones K, Dome J, eds. Renal tumors of childhood. Berlin: Springer, 2014: 1–17.

6 Pastore G, Znaor A, Spreafico F, Graf N, Pritchard-Jones K, Steliarova-Foucher E. Malignant renal tumours incidence and survival in European children (1978–1997): report from the automated childhood cancer information system project. Eur J Cancer 2006; 42: 2103–14.

7 Cancer Research UK, Public Health England. Chemotherapy, radiotherapy and tumour resection in England, 2013–2014 V2. 2018. http://www.ncin.org.uk/view?rid=3460 (accessed Sept 1, 2019).

8 England RJ, Haider N, Vujanic GM, et al. Mesoblastic nephroma: a report of the United Kingdom children’s cancer and leukaemia group (CCLG). Pediatr Blood Cancer 2011; 56: 744–48.

9 Gooskens SL, Houwing ME, Vujanic GM, et al. Congenital mesoblastic nephroma 50 years after its recognition: a narrative review. Pediatr Blood Cancer 2017; 64: e26437.

10 Van den Heuvel-Eibrink MM, van Tinteren H, Rehorst H, et al. Malignant rhabdoid tumours of the kidney (MRTKs), registered on recent SIOP protocols from 1993 to 2005: a report of the SIOP renal

tumour study group. Pediatr Blood Cancer 2011; 56: 733–37.

11 Brennan B, Stiller C, Bourdeaut F. Extracranial rhabdoid tumours: what we have learned so far and future directions. Lancet Oncol 2013; 14: 329–36.

12 Spreafico F, Collini P, Terenziani M, Marchiano A, Piva L. Renal cell carcinoma in children and adolescents. Expert Rev Anticancer Ther 2010; 10: 1967–78.

13 Selle B, Furtwängler R, Graf N, Kaatsch P, Bruder E, Leuschner I. Population-based study of renal cell carcinoma in children in Germany, 1980–2005: more frequently localized tumors and underlying disorders compared with adult counterparts. Cancer 2006; 107: 2906–14.

14 Gooskens SLM, Furtwängler R, Vujanic GM, Dome JS, Graf N, Van Den Heuvel-Eibrink MM. Clear cell sarcoma of the kidney: a review. Eur J Cancer 2012; 48: 2219–26.

15 Saltzman AF, Carrasco A, Weinman J, Meyers ML, Cost NG. Initial imaging for pediatric renal tumors: an opportunity for improvement. J Urol 2018; 199: 1330–36.

16 Dias SR, Olsen OE. Isotropic 3-D T2-weighted spin-echo for abdominal and pelvic MRI in children. Pediatr Radiol 2012; 42: 1385–90.

17 Littooij AS, Sebire NJ, Olsen OE. Whole-tumor apparent diffusion coefficient measurements in nephroblastoma: can it identify blastemal predominance? J Magn Reson Imaging 2017; 45: 1316–24.

18 Littooij AS, Humphries PD, Olsen OE. Intra- and interobserver variability of whole-tumour apparent diffusion coefficient measurements in nephroblastoma: a pilot study. Pediatr Radiol 2015; 45: 1651–60.

19 Humphries PD, Sebire NJ, Siegel MJ, Olsen OE. Tumors in pediatric patients at diffusion-weighted MR imaging: apparent diffusion coefficient and tumor cellularity. Radiology 2007; 245: 848–54.

20 Pearce MS, Salotti JA, Little MP, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet 2012; 380: 499–505.

21 Cauldwell C. Anesthesia risks associated with pediatric imaging. Pediatr Radiol 2011; 41: 949–950.

22 Kanda T, Ishii K, Kawaguchi H, Kitajima K, Takenaka D. High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology 2014; 270: 834–41.

23 Kaste SC, Brady SL, Yee B, et al. Is routine pelvic surveillance imaging necessary in patients with Wilms’ tumor? Cancer 2013; 119: 182–88.

24 Kan JH, Hwang M, Lowas SR, Hernanz-Schulman M. Impact of pelvic CT on staging, surveillance, and survival of pediatric patients with Wilms tumor and hepatoblastoma. AJR Am J Roentgenol 2011; 196: W515–18.

25 Brisse HJ, Smets AM, Kaste SC, Owens CM. Imaging in unilateral Wilms tumour. Pediatr Radiol 2008; 38: 18–29.

26 Servaes S, Khanna G, Naranjo A, et al. Comparison of diagnostic performance of CT and MRI for abdominal staging of pediatric renal tumors: a report from the Children’s Oncology Group. Pediatr Radiol 2015; 45: 166–72.